Japanese pharmaceutical company finds ivermectin has ‘antiviral effect’ against omicron, other COVID variants

Kowa said the renowned drug has antiviral properties against all existing strains of SARS-CoV2 and is expected to be widely-used as a coronavirus therapeutic.Read More